128 related articles for article (PubMed ID: 36351503)
21. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting.
Kumar M; Misra A; Mishra AK; Mishra P; Pathak K
J Drug Target; 2008 Dec; 16(10):806-14. PubMed ID: 18988064
[TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
[TBL] [Abstract][Full Text] [Related]
23. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
Vyas TK; Babbar AK; Sharma RK; Misra A
J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
[TBL] [Abstract][Full Text] [Related]
24. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
25. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.
Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):207-13. PubMed ID: 24825492
[TBL] [Abstract][Full Text] [Related]
26. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
[TBL] [Abstract][Full Text] [Related]
27. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
28. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
29. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
Mathure D; Ranpise H; Awasthi R; Pawar A
Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865
[TBL] [Abstract][Full Text] [Related]
30. Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.
El-Shenawy AA; Mahmoud RA; Mahmoud EA; Mohamed MS
AAPS PharmSciTech; 2021 May; 22(4):147. PubMed ID: 33948767
[TBL] [Abstract][Full Text] [Related]
31. Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis.
Bachhav SS; Dighe V; Mali N; Gogtay NJ; Thatte UM; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):785-799. PubMed ID: 32813265
[TBL] [Abstract][Full Text] [Related]
32. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
33. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
34. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation.
Patel MR; Patel RB; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):346-54. PubMed ID: 24865295
[TBL] [Abstract][Full Text] [Related]
35. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
[TBL] [Abstract][Full Text] [Related]
36. Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.
El-Setouhy DA; Ibrahim AB; Amin MM; Khowessah OM; Elzanfaly ES
Eur J Pharm Sci; 2016 Sep; 92():244-54. PubMed ID: 27154259
[TBL] [Abstract][Full Text] [Related]
37. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
38. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
39. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease.
Uppuluri CT; Ravi PR; Dalvi AV
Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426
[TBL] [Abstract][Full Text] [Related]
40. Exploring micellar-based polymeric systems for effective nose-to-brain drug delivery as potential neurotherapeutics.
Pokharkar V; Suryawanshi S; Dhapte-Pawar V
Drug Deliv Transl Res; 2020 Aug; 10(4):1019-1031. PubMed ID: 31858442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
